A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C
- PMID: 17175350
- DOI: 10.1016/j.transproceed.2006.10.040
A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C
Abstract
Rapid recurrence of severe hepatitis C (HCV) after liver transplantation is a major barrier to survival of the transplanted liver. While cyclosporine (CsA) in vitro has been shown to suppress HCV replication, an effect is not seen with tacrolimus (Tac). Evidence is inconsistent whether or how this translates to clinical practice. To expand the evidence on this issue, we analyzed graft survival and histological outcomes after liver transplantation for HCV hepatitis.
Methods: Using our longitudinal database (1991 onward) graft outcomes for all liver transplant recipients with HCV were evaluated (105 grafts in 97 patients). Severe activity, severe fibrosis, and graft survival were analyzed. All liver biopsies were scored (blinded) according to the Ludwig scale. Immunosuppression was based on prednisone and a calcineurin inhibitor (Tac n = 89, 85%; CsA n = 15, 14%). Comparisons of outcomes using CsA versus Tac therapy were done using survival analysis via the log-rank test.
Results: Graft survival was significantly better in the CsA group. Although there was no apparent difference in severe activity (grade 2), there was a statistically significant difference in graft survival without fibrosing cholestatic hepatitis (P = .01) and a trend toward a difference in fibrosis-free survival (P = 0.1). The rate of sustained response to antiviral therapy was twice as high in the CsA group, 50% versus 22% (P = 0.16; NS).
Conclusions: Graft survival in liver transplant recipients with HCV may be greater with CsA-based immunosuppression. There may also be a lower rate of fibrosing cholestatic hepatitis in this group.
Similar articles
-
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.World J Gastroenterol. 2014 Sep 14;20(34):12330-40. doi: 10.3748/wjg.v20.i34.12330. World J Gastroenterol. 2014. PMID: 25232269 Free PMC article. Review.
-
Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review.PLoS One. 2014 Sep 8;9(9):e107057. doi: 10.1371/journal.pone.0107057. eCollection 2014. PLoS One. 2014. PMID: 25198195 Free PMC article. Review.
-
Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.Transplant Proc. 2011 Apr;43(3):905-8. doi: 10.1016/j.transproceed.2011.02.034. Transplant Proc. 2011. PMID: 21486625
-
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.Transplantation. 2010 Dec 15;90(11):1204-9. doi: 10.1097/TP.0b013e3181fa93fa. Transplantation. 2010. PMID: 21068701 Clinical Trial.
-
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.Liver Transpl. 2002 Jan;8(1):40-6. doi: 10.1053/jlts.2002.29763. Liver Transpl. 2002. PMID: 11799484 Clinical Trial.
Cited by
-
Management of hepatitis C in patients with chronic kidney disease.World J Gastroenterol. 2015 Jan 14;21(2):408-22. doi: 10.3748/wjg.v21.i2.408. World J Gastroenterol. 2015. PMID: 25593456 Free PMC article. Review.
-
Cyclophilins as modulators of viral replication.Viruses. 2013 Jul 11;5(7):1684-701. doi: 10.3390/v5071684. Viruses. 2013. PMID: 23852270 Free PMC article. Review.
-
Cyclophilin inhibitors as a novel HCV therapy.Viruses. 2010 Aug;2(8):1621-1634. doi: 10.3390/v2081621. Epub 2010 Aug 5. Viruses. 2010. PMID: 21994697 Free PMC article.
-
Major challenges limiting liver transplantation in the United States.Am J Transplant. 2011 Sep;11(9):1773-84. doi: 10.1111/j.1600-6143.2011.03587.x. Epub 2011 Jun 14. Am J Transplant. 2011. PMID: 21672146 Free PMC article. Review.
-
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.Dig Dis Sci. 2010 Jan;55(1):196-203. doi: 10.1007/s10620-009-0981-3. Dig Dis Sci. 2010. PMID: 19798576 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous